AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05536726 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 608 Q4W
Description: 608 160 mg Q4W ( 3 cycles) +160 mg Q8W during maintenance period
Study NCT05536726 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive Placebo at pre-specified time points to maintain the blinding of the Investigational Medicinal Products.
Study NCT04614493 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SonoCloud-9 (SC9) device
Description: daily temozolomide (TMZ) during Radiation, followed by 6 months of adjuvant TMZ (5 days/months) with 6 concomitant Blood Brain Barrier opening sessions by ultrasound~+ 9 Blood Brain Barrier opening sessions by ultrasound without any associated drug
Study NCT04614493 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Temozolomide according Stupp protocol
Description: daily temozolomide (TMZ) during Radiation, followed by 6 months of adjuvant TMZ (5 days/months)
Study NCT04614493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide according Stupp protocol
Description: daily temozolomide (TMZ) during Radiation, followed by 6 months of adjuvant TMZ (5 days/months)
Study NCT05001711 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aria CV Acute PH System
Description: The Aria CV Acute PH System is indicated for evaluation of hemodynamic responses (e.g. pulmonary arterial compliance, cardiac output, and effective arterial elastance) to an intravascular Balloon catheter temporarily placed in the pulmonary artery in symptomatic adult patients with WHO Group 2 or WHO Group 3 pulmonary hypertension and right ventricular dysfunction.
Study NCT06260852 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostic Test: Visual Acuity Assessment
Description: Uncorrected visual acuity for nine distances (25, 28, 33, 40, 50, 60, 100, 200, 300 cm) examination via a Democritus Digital Acuity \& Reading Test (DDART).
Study NCT04988152 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sotrovimab
Description: sotrovimab IV infusion, single dose
Study NCT05554458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ChildTaks+ intervention
Description: The ChildTalks+ Intervention ChildTalks+ is a preventive intervention originally developed in the Netherlands, targeting children up to 18 years of age. It has been implemented in Norway, Italy, and Portugal. It has a clear and well-described theoretical basis focusing on psychoeducation. Its key strategy is to provide feasible and replicable interventions to improve the quality of life of families where parents are affected by a mental disorder.
Study NCT05554458 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ChildTaks+ intervention
Description: The ChildTalks+ Intervention ChildTalks+ is a preventive intervention originally developed in the Netherlands, targeting children up to 18 years of age. It has been implemented in Norway, Italy, and Portugal. It has a clear and well-described theoretical basis focusing on psychoeducation. Its key strategy is to provide feasible and replicable interventions to improve the quality of life of families where parents are affected by a mental disorder.
Study NCT00689806 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lovastatin
Description: Lovastatin 20 mg extended release (or placebo) by mouth once daily for weeks 1-4. Liver function test will be checked at week 4 follow up visit. If LFTs are not > 3 times the upper limit of normal, then the subject will have the dose of extended release lovastatin increased to 60 mg once a day for weeks 4-12
Study NCT00689806 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo by mouth once daily for weeks 1-4.
Study NCT04988152 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to Biologic
Description: Sterile 0.9% (w/v) sodium chloride solution
Study NCT04988152 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sotrovimab
Description: Sotrovimab IM injection, single dose
Study NCT06209814 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional denture
Description: Patients in this group received conventional maxillary and mandibular complete dentures. The patients used these dentures for 45 days. Then, the conventional maxillary denture was replaced by open faced denture with soft acryl resin wing.
Study NCT05922618 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: I-One
Description: I-ONE® is a medical device certified by the Ministry of Health as a Medical Device (risk class II A) for the treatment of inflammatory and degenerative tissue pathologies. The device consists of a signal generator and an applicator, called a solenoid. The solenoid will be placed on the joint, not necessarily in direct contact with the skin. The device works with a rechargeable battery and is equipped with an hour counter to assess patient compliance.~Treatment with I-ONE® therapy will start within 3-7 days of recruitment, will last 6 hours a day and will be maintained for 60 days. The treatment will be carried out at home and the device will be delivered directly to the patient's home by courier.
Study NCT04763434 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexamethasone; dexmedetomidine; ropivacaine
Description: Ultrasound-guided multilevelTPVB is performed at the end of lobectomy
Study NCT04763434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexamethasone; dexmedetomidine; ropivacaine
Description: Ultrasound-guided multilevelTPVB is performed at the end of lobectomy
Study NCT05964192 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Description: The theta burst stimulation (TBS) technique consists in administering bursts of transcranial magnetic stimulation (TMS) at very high frequency (50Hz) for 5 minutes (3 pulses of stimulation given at 50 hz; 10 bursts/1 s train; inter-train interval : 8 s; number of trains : 30; 100% resting motor threshold; number pulses/session : 900). Total number of sessions : 20 sessions (single daily session).
Study NCT06155162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The HuggyPuppy Intervention: Original doll
Description: The HuggyPuppy Intervention, originally designed to alleviate war-related stress in children (Sadeh et al., 2006), is a concise psychosocial intervention featuring a soft plush toy, originally a puppy, accompanied by a 'cover story.' This narrative informs the child that 'Huggy' is seeking care, prompting the child to adopt and comfort the toy. In the parent-delivered version tested in this trial, parents will receive three instructional videos (each lasting 1.5-5 minutes), guiding them on introducing the doll to their child. These videos encourage parents to foster a strong bond between the child and the doll, emphasizing activities such as hugging and expressing emotions through this comforting companion.
Study NCT06155162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The HuggyPuppy Intervention: Monkey doll
Description: The HuggyPuppy Intervention, originally designed to alleviate war-related stress in children (Sadeh et al., 2006), is a concise psychosocial intervention featuring a soft plush toy, originally a puppy, accompanied by a 'cover story.' This narrative informs the child that 'Huggy' is seeking care, prompting the child to adopt and comfort the toy. In this version children receive a plush monkey doll. In the parent-delivered version tested in this trial, parents will receive three instructional videos (each lasting 1.5-5 minutes), guiding them on introducing the doll to their child. These videos encourage parents to foster a strong bond between the child and the doll, emphasizing activities such as hugging and expressing emotions through this comforting companion.
Study NCT06155162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The HuggyPuppy Intervention: Dog without velcro doll
Description: The HuggyPuppy Intervention, originally designed to alleviate war-related stress in children (Sadeh et al., 2006), is a concise psychosocial intervention featuring a soft plush toy, originally a puppy, accompanied by a 'cover story.' This narrative informs the child that 'Huggy' is seeking care, prompting the child to adopt and comfort the toy. In this version children receive a plush dog doll, without velcro in palms. In the parent-delivered version tested in this trial, parents will receive three instructional videos (each lasting 1.5-5 minutes), guiding them on introducing the doll to their child. These videos encourage parents to foster a strong bond between the child and the doll, emphasizing activities such as hugging and expressing emotions through this comforting companion.
Study NCT06155162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The HuggyPuppy Intervention: Bear doll
Description: The HuggyPuppy Intervention, originally designed to alleviate war-related stress in children (Sadeh et al., 2006), is a concise psychosocial intervention featuring a soft plush toy, originally a puppy, accompanied by a 'cover story.' This narrative informs the child that 'Huggy' is seeking care, prompting the child to adopt and comfort the toy. In this version children receive a plush smiling bear doll. In the parent-delivered version tested in this trial, parents will receive three instructional videos (each lasting 1.5-5 minutes), guiding them on introducing the doll to their child. These videos encourage parents to foster a strong bond between the child and the doll, emphasizing activities such as hugging and expressing emotions through this comforting companion.
Study NCT06155162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The HuggyPuppy Intervention: Rabbit doll
Description: The HuggyPuppy Intervention, originally designed to alleviate war-related stress in children (Sadeh et al., 2006), is a concise psychosocial intervention featuring a soft plush toy, originally a puppy, accompanied by a 'cover story.' This narrative informs the child that 'Huggy' is seeking care, prompting the child to adopt and comfort the toy. In this version children receive a plush rabbit doll, with a neutral expression. In the parent-delivered version tested in this trial, parents will receive three instructional videos (each lasting 1.5-5 minutes), guiding them on introducing the doll to their child. These videos encourage parents to foster a strong bond between the child and the doll, emphasizing activities such as hugging and expressing emotions through this comforting companion.
Study NCT05690087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: intravenous lidocaine 2% bolus of 1.5 mg/kg over 5 min before induction of anesthesia followed by lidocaine infusion at 1.5 mg/kg/h intraoperatively until desufflation
Study NCT05690087 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sodium chloride 0.9% solution
Description: intravenous sodium chloride 0.9% solution volume matched bolus and infusion.
Study NCT06437496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-AAZTA-093
Description: Intravenous injection of one dosage of 111-148 MBq (3-4 mCi) 68Ga-AAZTA-093. Tracer doses of 68Ga-AAZTA-093 will be used to image lesions of prostate cancer by PET/CT.
Study NCT06446583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chewing sugar-free gum
Description: Upon arrival at the preoperative preparation room, patients begin chewing sugar-free gum provided by the preoperative nurse. They continue chewing until they enter the operating room (for at least 15 minutes). Before entering the operating room, it is confirmed that the gum has been discarded.
Study NCT06373003 — intervention group
Intervention type: OTHER
Intervention: Diagnostic accuracy
Description: To assess the diagnostic accuracy of non-criteria aPL (anti-vimentin/cardiolipin and anti-phosphatidylserine/prothrombin) in identifying APS in patients with thrombosis/ recurrent adverse pregnancy outcomes
Study NCT06437496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-PSMA-11//68Ga-PSMA-617
Description: Intravenous injection of one dosage of 111-148 MBq (3-4 mCi) 68Ga-PSMA-11//68Ga-PSMA-617. Tracer doses of 68Ga-PSMA-11/68Ga-PSMA-617 will be used to image lesions of prostate cancer by PET/CT.
Study NCT05269498 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CORTEXPLORER MED
Description: The CORTEXPLORER MED system is a platform that enables surgical navigation using real-time radiological images of patients. The application software formats patient-specific computed tomography or magnetic resonance images taken before surgery. These are displayed on the screen and through mixed reality from different perspectives (axial, sagittal, coronal, diagonal). Before surgery, the surgeon can then create, save and simulate the course along one or more surgical trajectories. As a visualization aid, the surgeon can also create and edit one or more 3D models of the anatomy. During surgery, the system tracks the position of specific surgical instruments in or on the patient's anatomy and continuously updates the position of the instruments on these images.
Study NCT05961020 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Total body vibration
Description: Whole-body vibration (WBV) training has been established as a useful method to improve physical fitness in obese individuals. Vibration stimulus during half squatting might suggest a long-term effect of WBV on the endocrine system
Study NCT05961020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: moderate restricted diet
Description: moderate restricted diet
Study NCT05125029 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botulinum toxin
Description: Botulinum toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum that prevents the release of the neurotransmitter acetylcholine from the neuromuscular junction, thereby preventing muscular contraction. Eligible subjects will be randomized 1:1:1 into three different groups: 1) placebo 2) 10 Units of BT injected per digit and 3) 20 units of BT injected per digit.
Study NCT06434922 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prevention Strategies
Description: Data collection sessions lasted approximately 1 to 1.50 hours, with education and foot care provided once a month. Subsequently, patients underwent monthly follow-ups for three months, during which they received guidance on foot examination, foot care, dietary habits, physical exercise, and stress management.
Study NCT06434922 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Standard Strategiies
Description: Group were educated about DM management, medication adherence, dietary practices, physical exercise routines, and foot care through pamphlets
Study NCT04899193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pergoveris FD
Description: Participants will be administered with 900 IU of recombinant human follicle-stimulating hormone (r-hFSH) and 450 IU of recombinant human luteinizing hormone (r-hLH) freeze-dried powder (Freeze-dried Pergoveris) as subcutaneous injection on Day 1 in investigation period 1 or investigation period 2 or investigation period 3. There will be a washout period of 6 days between investigation period 1 and investigation period 2 and 17 days between investigation period 2 and investigation period 3.
Study NCT04899193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pergoveris Liquid
Description: Participants will be administered with 900 IU of r-hFSH and 450 IU of r-hLH solution (Pergoveris Liquid) as subcutaneous injection using disposable pen-injector on Day 1 in investigation period 1 or investigation period 2 or investigation period 3. There will be a washout period of 6 days between investigation period 1 and investigation period 2 and 17 days between investigation period 2 and investigation period 3.
Study NCT04899193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gonal-f
Description: Participants will be administered with 900 IU of folitropin alfa (Gonal-f) as subcutaneous injection on Day 1 in investigation period 1 or investigation period 2 or investigation period 3. There will be a washout period of 6 days between investigation period 1 and investigation period 2 and 17 days between investigation period 2 and investigation period 3.
Study NCT04899193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luveris
Description: Participants will be administered with 450 IU of lutropin alfa (Luveris) as subcutaneous injection on Day 1 in investigation period 1 or investigation period 2 or investigation period 3. There will be a washout period of 6 days between investigation period 1 and investigation period 2 and 17 days between investigation period 2 and investigation period 3.
Study NCT06209814 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Maxillary open-faced denture
Description: Patients in this group received a maxillary open faced denture with soft acryl resin wing and a conventional mandibular complete denture. The patients used these dentures for 45 days. Afterward, the maxillary open-faced denture was replaced by one with a conventional construction.
Study NCT05738707 — intervention group
Intervention type: BIOLOGICAL
Intervention: Recombinant protein vaccine and adenovirus vector vaccine
Description: Administer recombinant protein vaccine and adenovirus vector vaccine
Study NCT05260359 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 6% Bemotrizinol (BEMT) in a basic sunscreen oil formulation
Description: SU E 101413 85
Study NCT05260359 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 6% Bemotrizinol (BEMT) dispersion in petrolatum
Description: SU-E-101413-82
Study NCT05260359 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sunscreen oil vehicle with 10% ethanol as penetration enhancer without BEMT
Description: SU E 101413 91
Study NCT05260359 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Petrolatum vehicle
Description: SU-E-101413-83
Study NCT05260359 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 0.9% Saline
Description: low irritancy control
Study NCT05260359 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sodium Lauryl Sulfate 0.1% (SLS)
Description: positive control
Study NCT05260359 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Undosed patch
Description: negative control
Study NCT06252766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experiment (Clown)
Description: Children included in the intervention group will be accompanied by a clown at the door from the moment they enter the intervention room and The child will be made to sit on the blood collection chair by playing games with them. Meanwhile, the nurse will take blood from the child. lasts for about 2-3 minutes. During this process, the clown is constantly playing games and foam will continue to distract you by blowing up balloons. The child's pain and anxiety score during the procedure the researcher will be evaluated by both the parent and the child. After the procedure is finished, the children will be will be taken out of the room and taken to the waiting area in the next room. Afterwards, the children will be asked how much pain and anxiety they felt during the blood collection procedure. After being allowed to rest for 1-2 minutes a questionnaire form will be applied to the children.
Study NCT05001061 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Misoprostol Pill
Description: sublingual versus vaginal Misoprostol in termination of first trimester missed abortion
Study NCT04819802 — intervention group
Intervention type: OTHER
Intervention: Measurement of sublingual microcirculation
Description: Sublingual microcirculation will be evaluated using a MicroScan (Microvision Medical, Amsterdam, the Netherlands) incident dark field imaging device. Perfusion measurements will be taken once a day during the first three days after inclusion (i.e. three measurement times). At each measurement time, five sequences of 20 secs will be recorded at five different sites. The video clips will be secondarily analyzed by a trained, blind investigator.
Study NCT04819802 — intervention group
Intervention type: OTHER
Intervention: Plasma sampling
Description: Additional volume during blood draw to assess plasma levels of the following endothelial markers: syndecan-1, angiopoietin-2, vascular endothelial growth factor-A (VEGF-A), thrombomodulin.
Study NCT06520332 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dental Implant Surgery - short implant group (less than or equal to 6mm)
Description: A mucoperiosteal flap will be raised in edentulous ridge. A short dental implant (experimental group) will be placed according to the standard protocol.~The platform of the implant will be placed 2 to 3 mm below CEJ of adjacent teeth.~The surgical wound closure will be coapted with mattress and single interrupted sutures
Study NCT06520332 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental Implant Surgery - Conventional implant group (greater than or equal to 10mm)
Description: A mucoperiosteal flap will be raised in edentulous ridge. A standard length implant ( comparative group) ( ≥10mm) will be placed according to the standard protocol in the augmented/native bone .~The platform of the implant will be placed 2 to 3 mm below CEJ of adjacent teeth.~The surgical wound closure will be coapted with mattress and single interrupted sutures
Study NCT06366399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance Exercise Timing
Description: 1 resistance exercise session consisting of 3 sets, 10 repetitions per set, on 12 different exercises
Study NCT05940623 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard care and home IOP telemonitoring with smart phone-based intervention
Description: We expect that (1) GAT measurements over 30 months of follow-up for patients randomized to Management Paradigm I to be smaller compared with those randomized to Management Paradigm II; and that (2) the rates of RNFL/GCIPL thinning would be slower for those randomized to Management Paradigm I compared with those randomized to Management Paradigm II
Study NCT06213467 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: diode laser 940nm
Description: Exposure for the two implants was done at the same visit, with one implant being exposed using diode laser and the other implant using traditional method